Company Description
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States.
It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services.
The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018.
Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
| Country | United States |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 371 |
| CEO | Nicholas Stewart Green B.Sc., MBA |
Contact Details
Address: 14191 Myford Road Tustin, California 92780 United States | |
| Phone | 714.508.6100 |
| Website | avidbio.com |
Stock Details
| Ticker Symbol | CDMO |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| CIK Code | 0000704562 |
| CUSIP Number | 05368M106 |
| ISIN Number | US05368M1062 |
| Employer ID | 95-3698422 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Stewart Green B.Sc., MBA | President, Chief Executive Officer and Director |
| Daniel R. Hart | Chief Financial Officer |
| Richard Richieri | Chief Operations Officer |
| Mark R. Ziebell J.D. | Vice President, General Counsel and Corporate Secretary |
| Matthew Kwietniak | Chief Commercial Officer |
| Oksana Lukash | Vice President of People |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2024 | 144 | Filing |
| Jul 2, 2024 | 10-K | Annual Report |
| Jul 2, 2024 | 8-K | Current Report |
| Apr 30, 2024 | 144 | Filing |
| Apr 26, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Apr 25, 2024 | 8-K | Current Report |
| Apr 24, 2024 | 10-Q | Quarterly Report |
| Apr 24, 2024 | 10-Q/A | [Amend] Quarterly report |
| Apr 24, 2024 | 10-Q/A | [Amend] Quarterly report |
| Apr 24, 2024 | 10-K/A | [Amend] Annual report |